Request for Covid-19 Impact Assessment of this Report
The United States Ophthalmic Pharmaceutical Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ophthalmic Pharmaceutical Drugs market, reaching US$ million by the year 2028. As for the Europe Ophthalmic Pharmaceutical Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ophthalmic Pharmaceutical Drugs players cover Allergan PLC, Bayer AG, F. Hoffmann-La Roche AG, and Johnson and Johnson Vision Care Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Pharmaceutical Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Prescription Drugs
Over-the-Counter Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Drug Stores
Online Pharmacies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Allergan PLC
Bayer AG
F. Hoffmann-La Roche AG
Johnson and Johnson Vision Care Inc
Kyowa Kirin Co., Ltd
Novartis International AG
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceuticals Co., Ltd.
Shire PLC
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Pharmaceutical Drugs Market Size 2017-2028
2.1.2 Ophthalmic Pharmaceutical Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ophthalmic Pharmaceutical Drugs Segment by Type
2.2.1 Prescription Drugs
2.2.2 Over-the-Counter Drugs
2.3 Ophthalmic Pharmaceutical Drugs Market Size by Type
2.3.1 Ophthalmic Pharmaceutical Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
2.4 Ophthalmic Pharmaceutical Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.4.4 Others
2.5 Ophthalmic Pharmaceutical Drugs Market Size by Application
2.5.1 Ophthalmic Pharmaceutical Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
3 Ophthalmic Pharmaceutical Drugs Market Size by Player
3.1 Ophthalmic Pharmaceutical Drugs Market Size Market Share by Players
3.1.1 Global Ophthalmic Pharmaceutical Drugs Revenue by Players (2020-2022)
3.1.2 Global Ophthalmic Pharmaceutical Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Ophthalmic Pharmaceutical Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ophthalmic Pharmaceutical Drugs by Regions
4.1 Ophthalmic Pharmaceutical Drugs Market Size by Regions (2017-2022)
4.2 Americas Ophthalmic Pharmaceutical Drugs Market Size Growth (2017-2022)
4.3 APAC Ophthalmic Pharmaceutical Drugs Market Size Growth (2017-2022)
4.4 Europe Ophthalmic Pharmaceutical Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Ophthalmic Pharmaceutical Drugs Market Size by Country (2017-2022)
5.2 Americas Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022)
5.3 Americas Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Pharmaceutical Drugs Market Size by Region (2017-2022)
6.2 APAC Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022)
6.3 APAC Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ophthalmic Pharmaceutical Drugs by Country (2017-2022)
7.2 Europe Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022)
7.3 Europe Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Pharmaceutical Drugs by Region (2017-2022)
8.2 Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ophthalmic Pharmaceutical Drugs Market Forecast
10.1 Global Ophthalmic Pharmaceutical Drugs Forecast by Regions (2023-2028)
10.1.1 Global Ophthalmic Pharmaceutical Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Ophthalmic Pharmaceutical Drugs Forecast
10.1.3 APAC Ophthalmic Pharmaceutical Drugs Forecast
10.1.4 Europe Ophthalmic Pharmaceutical Drugs Forecast
10.1.5 Middle East & Africa Ophthalmic Pharmaceutical Drugs Forecast
10.2 Americas Ophthalmic Pharmaceutical Drugs Forecast by Country (2023-2028)
10.2.1 United States Ophthalmic Pharmaceutical Drugs Market Forecast
10.2.2 Canada Ophthalmic Pharmaceutical Drugs Market Forecast
10.2.3 Mexico Ophthalmic Pharmaceutical Drugs Market Forecast
10.2.4 Brazil Ophthalmic Pharmaceutical Drugs Market Forecast
10.3 APAC Ophthalmic Pharmaceutical Drugs Forecast by Region (2023-2028)
10.3.1 China Ophthalmic Pharmaceutical Drugs Market Forecast
10.3.2 Japan Ophthalmic Pharmaceutical Drugs Market Forecast
10.3.3 Korea Ophthalmic Pharmaceutical Drugs Market Forecast
10.3.4 Southeast Asia Ophthalmic Pharmaceutical Drugs Market Forecast
10.3.5 India Ophthalmic Pharmaceutical Drugs Market Forecast
10.3.6 Australia Ophthalmic Pharmaceutical Drugs Market Forecast
10.4 Europe Ophthalmic Pharmaceutical Drugs Forecast by Country (2023-2028)
10.4.1 Germany Ophthalmic Pharmaceutical Drugs Market Forecast
10.4.2 France Ophthalmic Pharmaceutical Drugs Market Forecast
10.4.3 UK Ophthalmic Pharmaceutical Drugs Market Forecast
10.4.4 Italy Ophthalmic Pharmaceutical Drugs Market Forecast
10.4.5 Russia Ophthalmic Pharmaceutical Drugs Market Forecast
10.5 Middle East & Africa Ophthalmic Pharmaceutical Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Ophthalmic Pharmaceutical Drugs Market Forecast
10.5.2 South Africa Ophthalmic Pharmaceutical Drugs Market Forecast
10.5.3 Israel Ophthalmic Pharmaceutical Drugs Market Forecast
10.5.4 Turkey Ophthalmic Pharmaceutical Drugs Market Forecast
10.5.5 GCC Countries Ophthalmic Pharmaceutical Drugs Market Forecast
10.6 Global Ophthalmic Pharmaceutical Drugs Forecast by Type (2023-2028)
10.7 Global Ophthalmic Pharmaceutical Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Allergan PLC
11.1.1 Allergan PLC Company Information
11.1.2 Allergan PLC Ophthalmic Pharmaceutical Drugs Product Offered
11.1.3 Allergan PLC Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Allergan PLC Main Business Overview
11.1.5 Allergan PLC Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Ophthalmic Pharmaceutical Drugs Product Offered
11.2.3 Bayer AG Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 F. Hoffmann-La Roche AG
11.3.1 F. Hoffmann-La Roche AG Company Information
11.3.2 F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Product Offered
11.3.3 F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 F. Hoffmann-La Roche AG Main Business Overview
11.3.5 F. Hoffmann-La Roche AG Latest Developments
11.4 Johnson and Johnson Vision Care Inc
11.4.1 Johnson and Johnson Vision Care Inc Company Information
11.4.2 Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Product Offered
11.4.3 Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson and Johnson Vision Care Inc Main Business Overview
11.4.5 Johnson and Johnson Vision Care Inc Latest Developments
11.5 Kyowa Kirin Co., Ltd
11.5.1 Kyowa Kirin Co., Ltd Company Information
11.5.2 Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Product Offered
11.5.3 Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Kyowa Kirin Co., Ltd Main Business Overview
11.5.5 Kyowa Kirin Co., Ltd Latest Developments
11.6 Novartis International AG
11.6.1 Novartis International AG Company Information
11.6.2 Novartis International AG Ophthalmic Pharmaceutical Drugs Product Offered
11.6.3 Novartis International AG Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis International AG Main Business Overview
11.6.5 Novartis International AG Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Product Offered
11.7.3 Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Regeneron Pharmaceuticals, Inc.
11.8.1 Regeneron Pharmaceuticals, Inc. Company Information
11.8.2 Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Product Offered
11.8.3 Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Regeneron Pharmaceuticals, Inc. Main Business Overview
11.8.5 Regeneron Pharmaceuticals, Inc. Latest Developments
11.9 Santen Pharmaceuticals Co., Ltd.
11.9.1 Santen Pharmaceuticals Co., Ltd. Company Information
11.9.2 Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Product Offered
11.9.3 Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Santen Pharmaceuticals Co., Ltd. Main Business Overview
11.9.5 Santen Pharmaceuticals Co., Ltd. Latest Developments
11.10 Shire PLC
11.10.1 Shire PLC Company Information
11.10.2 Shire PLC Ophthalmic Pharmaceutical Drugs Product Offered
11.10.3 Shire PLC Ophthalmic Pharmaceutical Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Shire PLC Main Business Overview
11.10.5 Shire PLC Latest Developments
12 Research Findings and Conclusion
Table 1. Ophthalmic Pharmaceutical Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Prescription Drugs
Table 3. Major Players of Over-the-Counter Drugs
Table 4. Ophthalmic Pharmaceutical Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
Table 7. Ophthalmic Pharmaceutical Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
Table 10. Global Ophthalmic Pharmaceutical Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Ophthalmic Pharmaceutical Drugs Revenue Market Share by Player (2020-2022)
Table 12. Ophthalmic Pharmaceutical Drugs Key Players Head office and Products Offered
Table 13. Ophthalmic Pharmaceutical Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Ophthalmic Pharmaceutical Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Regions (2017-2022)
Table 18. Americas Ophthalmic Pharmaceutical Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Ophthalmic Pharmaceutical Drugs Market Size Market Share by Country (2017-2022)
Table 20. Americas Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
Table 22. Americas Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
Table 24. APAC Ophthalmic Pharmaceutical Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Ophthalmic Pharmaceutical Drugs Market Size Market Share by Region (2017-2022)
Table 26. APAC Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
Table 28. APAC Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
Table 30. Europe Ophthalmic Pharmaceutical Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Country (2017-2022)
Table 32. Europe Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
Table 34. Europe Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Ophthalmic Pharmaceutical Drugs
Table 43. Key Market Challenges & Risks of Ophthalmic Pharmaceutical Drugs
Table 44. Key Industry Trends of Ophthalmic Pharmaceutical Drugs
Table 45. Global Ophthalmic Pharmaceutical Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Ophthalmic Pharmaceutical Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Ophthalmic Pharmaceutical Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 51. Allergan PLC Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 52. Allergan PLC Ophthalmic Pharmaceutical Drugs Product Offered
Table 53. Allergan PLC Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Allergan PLC Main Business
Table 55. Allergan PLC Latest Developments
Table 56. Bayer AG Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 57. Bayer AG Ophthalmic Pharmaceutical Drugs Product Offered
Table 58. Bayer AG Main Business
Table 59. Bayer AG Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Bayer AG Latest Developments
Table 61. F. Hoffmann-La Roche AG Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Product Offered
Table 63. F. Hoffmann-La Roche AG Main Business
Table 64. F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. F. Hoffmann-La Roche AG Latest Developments
Table 66. Johnson and Johnson Vision Care Inc Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 67. Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Product Offered
Table 68. Johnson and Johnson Vision Care Inc Main Business
Table 69. Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson and Johnson Vision Care Inc Latest Developments
Table 71. Kyowa Kirin Co., Ltd Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 72. Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Product Offered
Table 73. Kyowa Kirin Co., Ltd Main Business
Table 74. Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Kyowa Kirin Co., Ltd Latest Developments
Table 76. Novartis International AG Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 77. Novartis International AG Ophthalmic Pharmaceutical Drugs Product Offered
Table 78. Novartis International AG Main Business
Table 79. Novartis International AG Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Novartis International AG Latest Developments
Table 81. Pfizer, Inc. Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 82. Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Product Offered
Table 83. Pfizer, Inc. Main Business
Table 84. Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer, Inc. Latest Developments
Table 86. Regeneron Pharmaceuticals, Inc. Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 87. Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Product Offered
Table 88. Regeneron Pharmaceuticals, Inc. Main Business
Table 89. Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Regeneron Pharmaceuticals, Inc. Latest Developments
Table 91. Santen Pharmaceuticals Co., Ltd. Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 92. Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Product Offered
Table 93. Santen Pharmaceuticals Co., Ltd. Main Business
Table 94. Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Santen Pharmaceuticals Co., Ltd. Latest Developments
Table 96. Shire PLC Details, Company Type, Ophthalmic Pharmaceutical Drugs Area Served and Its Competitors
Table 97. Shire PLC Ophthalmic Pharmaceutical Drugs Product Offered
Table 98. Shire PLC Main Business
Table 99. Shire PLC Ophthalmic Pharmaceutical Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Shire PLC Latest Developments
List of Figures
Figure 1. Ophthalmic Pharmaceutical Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ophthalmic Pharmaceutical Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type in 2021
Figure 7. Ophthalmic Pharmaceutical Drugs in Hospital Pharmacies
Figure 8. Global Ophthalmic Pharmaceutical Drugs Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Ophthalmic Pharmaceutical Drugs in Drug Stores
Figure 10. Global Ophthalmic Pharmaceutical Drugs Market: Drug Stores (2017-2022) & ($ Millions)
Figure 11. Ophthalmic Pharmaceutical Drugs in Online Pharmacies
Figure 12. Global Ophthalmic Pharmaceutical Drugs Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Ophthalmic Pharmaceutical Drugs in Others
Figure 14. Global Ophthalmic Pharmaceutical Drugs Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application in 2021
Figure 16. Global Ophthalmic Pharmaceutical Drugs Revenue Market Share by Player in 2021
Figure 17. Global Ophthalmic Pharmaceutical Drugs Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Ophthalmic Pharmaceutical Drugs Market Size 2017-2022 ($ Millions)
Figure 19. APAC Ophthalmic Pharmaceutical Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Europe Ophthalmic Pharmaceutical Drugs Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size 2017-2022 ($ Millions)
Figure 22. Americas Ophthalmic Pharmaceutical Drugs Value Market Share by Country in 2021
Figure 23. Americas Ophthalmic Pharmaceutical Drugs Consumption Market Share by Type in 2021
Figure 24. Americas Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application in 2021
Figure 25. United States Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Ophthalmic Pharmaceutical Drugs Market Size Market Share by Region in 2021
Figure 30. APAC Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application in 2021
Figure 31. China Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Country in 2021
Figure 38. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type in 2021
Figure 39. Europe Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application in 2021
Figure 40. Germany Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size Market Share by Application in 2021
Figure 48. Egypt Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Ophthalmic Pharmaceutical Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 54. APAC Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Europe Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 57. United States Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Canada Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 61. China Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Japan Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Korea Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 65. India Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Australia Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Germany Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 68. France Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 69. UK Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Italy Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Russia Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Spain Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Israel Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Ophthalmic Pharmaceutical Drugs Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...